Multicentrum Neo Mamma DHA

Multicentrum Neo Mamma DHA is a specialized dietary supplement designed for postpartum and breastfeeding women to support their nutritional needs and the healthy development of their infants. The 'Multicentrum' brand is the European and international branding for the multivitamin line known as 'Centrum' in North America.

The brand's history dates back to the 1950s when Dr. Leon Ellenbogen at Lederle Laboratories began researching vitamins, leading to the first commercial launch in 1978. Through a series of corporate mergers and spin-offs, the brand transitioned from Lederle to Wyeth, then to Pfizer, and eventually became part of a joint venture between Pfizer and GSK.

Today, Multicentrum is owned by Haleon, a global consumer healthcare company that was spun off as an independent entity in 2022. While the brand has global reach and manufacturing facilities in various regions, specific versions like 'Neo Mamma' are frequently produced in Italy to serve the European market.